Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer

Oncologist - United States
doi 10.1634/theoncologist.2012-0115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Evidence for the Role of Bevacizumab in the Treatment of Advanced Metastatic Breast Cancer: A Review

Breast Cancer: Targets and Therapy
Oncology
2010English

Modeling Efficacy of Bevacizumab Treatment for Metastatic Colon Cancer

Journal of Cancer
Oncology
2013English

American Academy of Physical Medicine and Rehabilitation Position Statement on Opioid Prescribing

PM and R
Physical TherapySports ScienceSports TherapyNeurologyMedicineRehabilitation
2018English

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis

Oncologist
Cancer ResearchMedicineOncology
2017English

Metastatic Breast Cancer: Focus on Capecitabine

Clinical Medicine Reviews in Oncology
2010English

Precision Medicine for Metastatic Breast Cancer

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2015English

Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2012English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy